baber/WOPTO huggingface dataset:
Patent ES-2033625-T1 (ES)
IPC: E21B12/00
Filed: 1991-02-12
Abstract: An assembly of wear element (11) for installation on the wearable part of a structure engageable with abrasive material including a relatively elongated base element adapted to be secured to the wearable part and a relatively elongated wear element releasably, reversibly mounted on the base element, each of the elements having longitudinally spaced apart dovetail surfaces (30) in one outstanding wall portion and at least one surface in a second opposed outstanding wall portion positioned between the spaced art dovetail surfaces. A method of designing the dovetail connection through a repeating pattern is also disclosed. <IMAGE>
Patent ES-2106695-T1 (ES)
Inventor: GOLOVISTIKOV IVAN NIKOLAEVICH
IPC: G01N33/53
Filed: 1995-03-16
Abstract: The method for determining a suppressor component of human immune status comprises collecting peripheral blood, obtaining a suspension of mononuclear cells (MNCs), dividing said suspension into two equal portions, cultivating MNCs in the first portion without a suppressor activator, cultivating MNCs in the second portion with said suppressor activator (TBG), washing MNCs out of culture medium, blocking the proliferation, adding newly isolated MNCs from a normal donor, which MNCs have been stimulated with phytohemagglutinin, into each of MNC portions in equal proportions to obtain test cultures, cultivating said test cultures, further evaluating the proliferation in said test cultures and determining the suppression value on the basis of the ratios of proliferation levels in test cultures.
Patent ES-2120394-T1 (ES)
Inventor: SCHLOSSER MICHAEL
IPC: A45D34/04
Filed: 1997-08-25
Abstract: The elongated applicator element (12,14) holds the cosmetic product and dispenses it by contact onto the hair or skin. The applicator element extends along a peripheral line which is convex in parts at least. The width of the applicator element is, or is not, constant over its length. When viewed from above, the applicator element is straight or not straight at least in parts. The applicator element is decorated with designs; is adjustable in breadth, length and peripheral shape; and has a grip (18).
Patent ES-2164626-T1 (ES)
Inventor: GRAVEL DENIS
IPC: A61P17/02
Filed: 1999-09-07
Abstract: The present invention relates to chimeric fatty body-GRF analogs with increased biological potency, their application as anabolic agents and in the diagnosis and treatment of growth hormone deficiencies. The chimeric fatty body-GRF analogs include an hydrophobic moiety (tail), and can be prepared, either by anchoring at least one hydrophobic tail to the GRF, in the chemical synthesis of GRF. The GRF analogs of the present invention are biodegradable, non-immunogenic and exhibit an improved anabolic potency with a reduced dosage and prolonged activity.
Patent CY-1110425-T1 (CY)
Inventor: SPEELMANS GELSKE
IPC: A23L33/00
Filed: 2008-12-30
Abstract: The present invention relates to the field of prebiotics. Provided are uses for compositions comprising synergistically effective amounts of polyfructose and galactooligosaccharides (GOS).
Patent CY-1110088-T1 (CY)
Inventor: KLATT AXEL
IPC: H04W28/08
Filed: 2010-06-16
Abstract: A method for optimizing the load distribution between one mobile radio network, for example using the UMTS standard, and another mobile radio network, for example using the GSM standard, by optimizing the signalling sequence when establishing a connection in such a mobile radio system. It enables efficient cooperation when establishing a connection, for example a voice connection, between a UMTS and a GSM network. In addition to the efficient use of resources in a UMTS system, the method also enables direct establishment of a connection, for example of a voice connection that was initiated in a UMTS network, in a GSM network.
Patent CY-1116851-T1 (CY)
Title: Χρηση συνθεσης ψεκασματος κλομπεταζολης για την θεραπευτικη αγωγη της ψωριασης
Inventor: DOW GORDON J
IPC: A61K31/045
Filed: 2015-08-19
Abstract: Η παρούσα εφεύρεση δίδει μία μέθοδο για τη θεραπευτική αγωγή της ψωρίασης δια ψεκασμού επί του δέρματος, όπου εμφανίζεται η ψωρίαση, καθημερινά, επί τουλάχιστον 4 βδομάδες μίας φαρμακευτικής σύνθεσης η οποία περιέχει μία αποτελεσματική ποσότητα προπιονικής κλομπεταζόλης. Μία προτιμώμενη φαρμακευτική σύνθεση η οποία περιέχει προπιονική κλομπεταζόλη, αιθυλαλκοόλη, μυριστικό ισοπροπυλεστέρα και ανιονικό επιφανειοδραστικό.
Patent CY-1117417-T1 (CY)
Title: Νιτροοξυπαραγωγα προσταγλανδινης
Inventor: ONGINI ENNIO
IPC: C07C405/00
Filed: 2016-04-26
Abstract: Περιγράφονται νιτροοξυπαράγωγα της προσταγλανδίνης, τα οποία έχουν βελτιωμένη φαρμακολογική δραστικότητα και ενισχυμένη ανεκτικότητα. Μπορούν να χρησιμοποιούνται για την αγωγή του γλαυκώματος και την οφθαλμική υπέρταση.
Patent CY-1117633-T1 (CY)
Title: Χρηση toy streptococcus salivarius στη θεραπευτικη αντιμετωπιση χρονιων λοιμωξεων του αναπνευστικου συστηματος
Inventor: STEFANI STEFANIA
IPC: A61P11/00
Filed: 2016-06-14
Abstract: Η παρούσα εφεύρεση παρέχει ένα νέο μικροβιακό στέλεχος του είδους Streptococcus salivarius για χρήση στη θεραπευτική αντιμετώπιση φλεγμονωδών διαδικασιών με ή χωρίς λοιμώδη αιτιολογία. Ένα περαιτέρω αντικείμενο της παρούσας εφεύρεσης είναι συνθέσεις που περιλαμβάνουν το αναφερθέν στέλεχος και χρήσεις αυτού.
Patent CY-1119101-T1 (CY)
Title: Ναφθαλινο-ισοξαζολινες ως παραγοντες καταπολεμισης ασπονδυλων παρασιτων
Inventor: LAHM GEORGE PHILIP
IPC: C07D261/04
Filed: 2017-07-05
Abstract: Αποκαλύπτονται ενώσεις του Τύπου (I), όπου το R1 είναι αλογόνο, C1-C2 αλογονοαλκύλ ή C1-C2 αλογονοαλκόξυ· το R2 είναι Η, αλογόνο ή κυανό· το R3 είναι Η, αλογόνο ή CF3· το R4 είναι Η, C2-C7 αλκυλοκαρβονύλ ή C2-C7 αλκοξυκαρβονύλ και το R5 είναι C1-C6 αλκύλ ή C1-C6 αλογονοαλκύλ, εκάστη υποκατεστημένη με έναν υποκαταστάτη ανεξαρτήτως επιλεγόμενο από υδρόξυ, C1-C6 αλκόξυ, C1-C6 αλκύλθειο, C1-C6 αλκυλσουλφινύλ, C1-C6 αλκυλσουλφονύλ, C2-C7 αλκυλαμινοκαρβονύλ, C3-C9 διαλκυλαμινοκαρβονύλ, C2-C7 αλογονοαλκυλαμινοκαρβονύλ και C3-C9 αλογονοδιαλκυλαμινοκαρβονύλ. Επίσης αποκαλύπτονται συνθέσεις που περιέχουν τις ενώσεις του Τύπου (I) και μέθοδοι για έλεγχο ασπόνδυλου παράσιτου που περιλαμβάνουν επαφή του ασπόνδυλου παράσιτου ή του περιβάλλοντος αυτού με βιολογικώς δραστική ποσότητα ένωσης ή σύνθεσης της εφεύρεσης.
Patent CY-1120513-T1 (CY)
Inventor: SO TONY WAI-CHIU
IPC: A61Q7/00
Filed: 2018-05-18
Abstract: A pharmaceutical composition for topical administration, including, as the pharmaceutically active component, at least 5% by weight, based on the total weight of the composition of a piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof; an acid in an amount to completely solubilise the piperidinopyrimidine derivative or a pharmaceutically acceptable salt thereof; a solvent composition including at least two of water, a lower alcohol and a co-solvent selected from one or more of the group consisting of aromatic and polyhydric alcohols; wherein when the co-solvent includes propylene glycol, it is present in an amount of less than approximately 10% by weight.
Patent CY-1121127-T1 (CY)
Title: Συσκευες για τη συζευξη δεικτοδοτημενης διαταξης βαλβιδας και δοχειου υπο πιεση με ενα περιλαιμιο
Inventor: MONTGOMERY FREDERICK J
IPC: A61M16/20
Filed: 2019-01-16
Abstract: Αποκαλύπτεται μία δεικτοδοτημένη συσκευή περιέκτη δραστικής ουσίας (24) για μία δεικτοδοτημένη συσκευή ενεργοποίησης δραστικής ουσίας (10) για χρήση σε μία δεικτοδοτημένη συσκευή χορήγησης και ρύθμισης δραστικής ουσίας (70). Η δεικτοδοτημένη συσκευή περιέκτη δραστικής ουσίας (24) περιλαμβάνει ένα περίβλημα (26) και μία βαλβίδα (42), όπου η βαλβίδα (42) είναι διατεταγμένη εντός του περιβλήματος (26), ένα δοχείο αερίου (28) σε επικοινωνία ρευστών με τη βαλβίδα (42), όπου το δοχείο (28) περιέχει ένα δραστικό φαρμακευτικό συστατικό και έναν ανενεργό αέριο φορέα, όπου το δοχείο (28) είναι ευθυγραμμισμένο κατά μήκος ενός διαμήκους άξονα (21), όπου η βαλβίδα (42) είναι δυνατόν να ενεργοποιείται αξονικά κατά μήκος του διαμήκους άξονα (21), ένα πρώτο δεικτοδοτημένο στοιχείο ενσωματωμένο προς το περίβλημα (26) και ένα τρίτο δεικτοδοτημένο στοιχείο ενσωματωμένο προς το περίβλημα (26), όπου το πρώτο δεικτοδοτημένο στοιχείο είναι προσαρμοσμένο ώστε να είναι συμπληρωματικό προς ένα δεύτερο δεικτοδοτημένο στοιχείο ενός περιλαιμίου (12) της δεικτοδοτημένης συσκευής ενεργοποίησης δραστικής ουσίας (10), όπου το δεύτερο δεικτοδοτημένο στοιχείο είναι ένα πρώτο κλειδί (18), το τρίτο δεικτοδοτημένο στοιχείο είναι προσαρμοσμένο ώστε να είναι συμπληρωματικό προς ένα τέταρτο δεικτοδοτημένο στοιχείο του περιλαιμίου (12) της δεικτοδοτημένης συσκευής ενεργοποίησης δραστικής ουσίας (10), όπου το τέταρτο δεικτοδοτημένο στοιχείο είναι ένα δεύτερο κλειδί, όπου το πρώτο δεικτοδοτημένο στοιχείο είναι μη-συμπληρωματικό προς το τέταρτο δεικτοδοτημένο στοιχείο και όπου το τρίτο δεικτοδοτημένο στοιχείο είναι μη-συμπληρωματικό προς το δεύτερο δεικτοδοτημένο στοιχείο.
Patent CY-1124507-T1 (CY)
Title: Νεος αναστολεας μεκ για τη θεραπευτικη αγωγη των ιικων και βακτηριακων λοιμωξεων
Inventor: LUDWIG STEPHAN
IPC: A61K31/196
Filed: 2021-08-24
Abstract: Η παρούσα εφεύρεση αναφέρεται στο PD-0184264 για χρήση σε μια μέθοδο για την προφύλαξη ή/και τη θεραπεία μιας συν-μόλυνσης που περιλαμβάνει μια βακτηριακή λοίμωξη και μια λοίμωξη από τον ιό της γρίπης ή μια ιική ή βακτηριακή λοίμωξη μόνο. Επίσης παρέχονται συνθέσεις όπως αναστολείς για χρήση στην προφύλαξη ή/και τη θεραπεία μιας συν-μόλυνσης που περιλαμβάνει μια βακτηριακή λοίμωξη και μια λοίμωξη από τον ιό της γρίπης ή μια βακτηριακή ή ιική λοίμωξη μόνο.
Patent CY-1126099-T1 (CY)
Title: Φαρμακευτικη συνθεση που περιεχει κρυσταλλικη τοσυλικη σοραφενιμπη
Inventor: SCHELER STEFAN
IPC: A61K9/20
Filed: 2023-07-18
Abstract: Η παρούσα εφεύρεση σχετίζεται μια στερεά δοσολογική μορφή από του στόματος, ιδίως ένα δισκίο, που περιλαμβάνει τοσυλική σοραφενίμπη πολυμορφικής μορφής III.
Patent HR-P20100363-T1 (HR)
Title: New combinations of a 5-ht3 receptor antagonist with racecadotril or dexecadotril
Inventor: SCHWARTZ JEAN-CHARLES
IPC: A61K31/265
Filed: 2010-06-29
Abstract: The present invention concerns new combinations of an anti-emetic agent and an enkephalinase inhibitor, the uses of said combinations for treating diarrhea and/or gastroenteritis.
Patent HR-P20100415-T1 (HR)
Title: DRY CONCENTRATE FOR MAKING DIETETIC SOFT DRINK CONTAINING Fe, BEE BREAD AND VITAMIN C AND ITS PRODUCTION PROCESS
Inventor: MOGOROVIC MILOS
IPC: A23L21/20
Filed: 2010-07-26
Abstract: This invention falls in the field of non-alcoholic drinks and it solves the problem of getting dry concentrate for making a soft dietetic drink with iron, vitamin C and beebread whose positive physiological properties are considerably prolonged. This has been achieved so that dry concentrate according to the invention in example 1 is made in precise measured mass% and through a specific process of the following prepared and mixed components: triturate of beebread 0,175 mass%, chelate iron 0,425 mass%, vitamin C 0,4 mass%, anhydrous citric acid 3,75 mass%, mixture of aroma and color 4 mass% , SiO<SUB>2</SUB>1 mass% and sucrose 90,25 mass%.
Patent HR-P20110539-T1 (HR)
Inventor: HUGHES ROBERT O
IPC: C07D471/04
Filed: 2011-07-20
Abstract: Spoj, ili farmaceutski prihvatljiva sol spoja, naznačen time što spoj ima strukturu Formule I: te time što: R2 se bira iz skupine koju čine aril i 3- do 10-eročlani heterociklilni prsten, gdje navedeni R2 arilni i heterociklilni supstituenti mogu izborno biti supstituirani s jednim ili više supstituenata, koje se neovisno bira iz skupine koju čine halogen, cijano, nitro, okso, alkil, alkenil, alkinil, cikloalkil, OR201, -C(O)R201, -OC(O)R201, -C(O)OR201, -NR201R202, -N(R202)C(O)R202, -C(O)NR201R202, -C(O)NR201C(O)R202, -SR201, -S(O)R201 i -S(O)2R201; gdje navedeni alkilni, alkenilni, alkinilni i cikloalkilni supstituenti mogu izborno biti supstituirani s jednim ili više supstituenata, koje se neovisno bira iz skupine koju čine halogen, okso, -OR203 i -C(O)OR203;R201, R202 i R203 se neovisno bira iz skupine koju čine vodik i alkil, gdje navedeni alkil može izborno biti supstituiran s jednim ili više supstituenata, koje se neovisno bira iz skupine koju čine halogen, hidroksi, alkoksi, karboksi i -C(O)NH2;R6A i R6B, zajedno s dušikom na koji su vezani, tvore djelomično ili posve zasićeni 3- do 14-eročlani heterociklilni prsten, gdje heterociklil može izborno biti supstituiran s jednim ili više supstituenata, koje se neovisno bira iz skupine koju čine vodik, halogen, okso, alkil, alkenil, alkinil, cijano, cikloalkil, aril, heterociklil, -OR601, -C(O)R601, OC(O)R601, -C(O)OR601, -NR601R602, -N(R601)C(O)R602, -C(O)NR601R602 i -C(O)NR601C(O)R602, gdje (a) navedeni alkilni, alkenilni, alkinilni i cikloalkilni supstituenti mogu izborno biti supstituirani s jednim ili više supstituenata, koje se neovisno bira iz skupine koju čine halogen, cijano, okso, -OR603, -C(O)R603, -C(O)OR603, -OC(O)R603, -NR603R604, -N(R603)C(O)R604, -C(O)NR603R604, -C(O)NR603C(O)R604, -SR603, -S(O)R603, -S(O)2R603, -N(R603)S(O)2R604, -S(O)2NR603R604, C(O)NR603C(O)R604, -SR603, -S(O)R603, -S(O)2R603, -N(R603)S(O)2R604 i -S(O)2NR603R604, i (b) navedeni arilni i heterociklilni supstituenti mogu izborno biti supstituirani s jednim ili više supstituenata, koje se neovisno bira iz skupine koju čine halogen, alkil, alkenil, alkinil, cijano, okso, -OR601, -C(O)R601, -C(O)OR601, -OC(O)R601- NR601 R602, -N(R601)C(O)R602, -C(O)NR601R602, -C(O)NR601C(O)R602, -SR601, -S(O)R602, -S(O)2R601, -N(R601)S(O)2R602 i -S(O)2NR601R602;R601, R602, R603 i R604 se neovisno bira iz skupine koju čine vodik, alkil, alkenil, i alkinil, gdje (a) navedeni R601 i R602 alkil mogu izborno biti supstituirani s jednim ili više supstituenata, koje se neovisno bira iz skupine koju čine halogen, cijano, hidroksi, karboksi, okso, alkenil, alkinil, halogenalkenil, hidroksialkenil, karboksialkenil, halogenalkinil, hidroksialkinil, karboksialkinil, alkoksi, halogenalkoksi, hidroksialkoksi i karboksialkoksi, i (b) navedeni R601 i R602 alkenilni i alkinilni supstituenti mogu izborno biti supstituirani s jednim ili više supstituenata, koje se neovisno bira iz skupine koju čine halogen, cijano, hidroksi, karboksi, okso, alkoksi,
Patent HR-P20110692-T1 (HR)
Title: Advertising panel support device
Inventor: CARMO SERGE JOSU DO
IPC: G09F21/04
Filed: 2011-09-27
Abstract: The device has angle irons holding a double sided panel by a fixation screw and nut. Each iron has an end, which is opposite to the panel, for holding upper part of a spring (4) using a screw (7) on a pin (8). Each spring has a lower part fixed on a magnet (5) protected by a cap (6). The irons induce traction force on the springs on the wind side and thrust force on the springs on the side opposite to wind.
Patent SI-1569904-T1 (SI)
Title: Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
Inventor: LU XIAN-PING
IPC: A61P3/04
Filed: 2003-11-21
Abstract: Disclosed is the preparation and pharmaceutical use of substituted arylalcanoic acid derivatives of Formula I, wherein ring A, ring B, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, X, Alk<SUP>1</SUP>, Alk<SUP>2</SUP>, Ar<SUP>1</SUP>, and Ar<SUP>2 </SUP>are as defined in the specification. These compounds, as selective agonists activating peroxisome proliferator-activated receptors (PPAR), in particularly the RXR/PPARalpha, RXR/PPARgamma, and RXR/PPARdelta heterodimers, are useful in the treatment and/or prevention of type 2 diabetes and associated metabolic syndrome such as hypertension, obesity, insulin resistance, hyperlipidemia, hyperglycemia, hypercholesterolemia, atherosclerosis, coronary artery disease, and other cardiovascular disorders with improved side effects profile commonly associated with conventional PPARgamma agonists.
Patent SI-1653343-T1 (SI)
Title: Invalidating storage, clearing buffer entries
Inventor: SLEGEL TIMOTHY
IPC: G06F12/08
Filed: 2004-05-06
Abstract: A method for invalidating translation table entries and clearing corresponding dynamic address translation (DAT) table entries of a translation lookaside buffer (TLB) associated with a processing unit in a computer system, the computer system comprising one or more address translation tables providing translation information to translate virtual addresses to real addresses, wherein address translation table entry information is maintained in the TLB, the method comprising: a) fetching for execution a multifunction Invalidate DAT Table Entry (IDTE) machine instruction, the IDTE instruction comprising an opcode field identifying said instruction and an information field comprising: 1) a first register field for identifying a first register for indicating an origin and type of an address translation table containing a range of one or more entries to be invalidated, 2) a second register field for identifying a second register for including indices used to select a translation table entry in a type of address translation table indicated by the first register, and an option bit for indicating whether a clear by address space control element (ASCE) operation or an invalidating-and-clearing operation is to be performed, and a range field for identifying a number of additional translation table entries, in the address translation table indicated by the first register, to be invalidated, and 3) a third register field for identifying a third register for indicating an origin and type of address translation table to be used when the clear by address space control element operation is to be performed for only selectively clearing TLB entries; and b) executing the fetched IDTE machine instruction, the executing step comprising: 
i. determining, from the option bit in the second register, whether a clear by address space control element operation is to be performed; 
ii. responsive to the option bit indicating that the clear by address space control element operation is to be performed, clearing the TLB, independent of the content of the first register, of those entries in which the address translation table origin of a translation table was used to create the entries in the TLB corresponds to the address translation table origin in the third register; 
iii. responsive to the option bit indicating that the clear by address space control element operation is not to be performed, invalidating the range of address translation table entries of a translation table identified by the range field, and clearing the TLB entries corresponding to the invalidated entries.
Patent SI-1707497-T1 (SI)
Title: Package forming at least one pocket
Inventor: LENOIR NICOLAS
IPC: B65D75/00
Filed: 2005-03-29
Abstract: The package (10) forming at least one pocket delimited by at least one flexible film (12) having two principal faces (14, 16) which are connected to one another along at least two opposing transverse connecting lines (18, 20) which delimit the said pocket between them, characterised in that a first face (14) has a length measured between the two opposing connecting lines which is less than the length measured between the two opposing connecting lines of the second face (16), and in that the first face has a weakened line (40) between the two opposing connecting lines (18, 20).
Patent SI-1773911-T1 (SI)
Title: Adhesive compositions and methods of using the same
Inventor: PARHAR AMRIT K
IPC: C08G63/00
Filed: 2005-07-20
Abstract: Adhesive compositions are described which comprise at least one organic sulfoxide, sulfone or sulfide and at least one ketone, ether, ester, amide or carbonate or a mixture thereof. The adhesive compositions also may contain one or more water insoluble polymers such as ABS, PVC and CPVC. Methods of adhesively bonding or welding a first plastic surface to a second plastic surface using these adhesive compositions also are described.
Patent TR-201000585-T1 (TR)
Title: Sesli kontrol sistemi.
Inventor: ARGAT SUEREYYA ATILLA
IPC: G01C21/36
Filed: 2008-08-18
Abstract: Bu buluş, otomobillerde kullanılmak üzere tasarlanan sesli kontrol sistemi ile ilgilidir. Bu buluşun amacı, tekniğin bilinen durumunda bulunmayan Türkçe tanıyan ve Türkçe veri deposuna sahip olan bir sistem gerçekleştirmektir.
Patent DE-3587632-T2 (DE)
Inventor: COX JAMES P
IPC: A61L9/01
Filed: 1985-02-26
Granted: 1994-02-17
Abstract: Counteracting malodors or pungency of ammonical substances with a composition of citrus oil material or oil material containing limonene as a natural component processed with material selected from the group consisting of sodium bisulfate, potassium bisulfate, sodium bisulfite, potassium bisulfite, sodium metabisulfite, sulfur dioxide, sodium perchlorate, potassium perchlorate, perchloric acid, sodium perborate, potassium perborate, potassium dichromate, potassium permanganate, sodium nitrate, potassium nitrate, ozone, hydrogen peroxide and aqueous sodium peroxide in conjunction with sulfuric acid, and suspended in a vehicle of glacial acetic acid and amyl alcohol, amyl acetate or butyl acetate. The composition may contain aldehyde such as vanillin, syringaldehyde, anisaldehyde or benzaldehyde.
Patent DE-3650089-T2 (DE)
Inventor: VAN DER LELY CORNELIS
IPC: A01J5/017
Filed: 1986-01-22
Granted: 1995-04-27
Abstract: The appts. includes a milking parlour, a milking machine and at least one computer. The milking cluster (18) is provided with one or more sensors (33) which determine whether or not the cluster is correctly attached to teats of an udder. The milking operation is switched on only if it is determined that the milking cluster is correctly attached, and attachment repeated if correct attachment fails. A sensor (16) is also proVided to determine whether the animal is in the appropriate position in the milking parlour, the automatic milking operation being discontinued if it is determined that the animal is not in the correct position. An arrangement (2,3,12,27) may also be provided for correcting the posture or positioning of the animal.
Patent DE-3650123-T2 (DE)
Inventor: SPEK JOHAN DIRK
IPC: H03K19/20
Filed: 1986-06-24
Granted: 1995-03-09
Abstract: PCT No. PCT/NL86/00017 Sec. 371 Date Apr. 6, 1987 Sec. 102(e) Date Apr. 6, 1987 PCT Filed Jun. 24, 1986 PCT Pub. No. WO87/00367 PCT Pub. Date Jan. 15, 1987.An electronic circuit element with field-effect operation and with such characteristics that its source terminal (2) is to be connected, in the case of an N-type element (1a) to the positive, and in the case of a P-type element (1b) to the negative pole of a current source, said element (1) being non-conducting if its gate terminal is at the voltage of the pole connected with the drain terminal (3). This element (1) can be used as a memory circuit, for forming a trivalent switching circuit, and as an analogue amplifier with a negative resistance characteristic. Such an element (1) can be assembled from a series connection of an n-type and a p-type field-effect transistor (11a, 11b) having their source electrodes (12) interconnected, the gate terminal (4) being formed by the gate electrode (14) of the n-type or p-type transistor (11a, 11b) resp., the gate electrode (14) of the other transistor being connected with the drain electrode (13) of the first one.